Biogen is a biotech company that researches, develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases worldwide. The company is the market leader in drugs that treat multiple sclerosis and has recently introduced the first approved treatment for spinal muscular atrophy. The company also sells products that treat plaque psoriasis, non-Hodgkin's lymphoma, lymphocytic leukemia and rheumatoid arthritis. Current research continues on multiple sclerosis and has expanded to include neuroimmunology, Alzheimer's d
ABBV
AZN
AZN
MRK
BMY
Jasper Hellweg
Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology